HER-2/NEU (HER2) peptide based vaccine with FLT3 ligand (FL) +/- GM-CSF as an adjuvant.

被引：0
|
作者：
Disis, ML
Rinn, K
Davis, D
Caron, D
Schiffman, K
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Immunex Corp, Seattle, WA USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1961
引用
收藏
页码：456A / 456A
页数：1
相关论文
共 50 条
  • [1] Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine
    Yo, Y-T
    Hsu, K-F
    Shieh, G-S
    Lo, C-W
    Chang, C-C
    Wu, C-L
    Shiau, A-L
    CANCER GENE THERAPY, 2007, 14 (11) : 904 - 917
  • [2] Coexpression of Flt3 ligand and GM-CSF genes modulates immune responses induced by HER2/neu DNA vaccine
    Y-T Yo
    K-F Hsu
    G-S Shieh
    C-W Lo
    C-C Chang
    C-L Wu
    A-L Shiau
    Cancer Gene Therapy, 2007, 14 : 904 - 917
  • [3] FIG ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers
    Disis, ML
    Rinn, K
    Knutson, KL
    Davis, D
    Caron, D
    dela Rosa, C
    Schiffman, K
    BLOOD, 2002, 99 (08) : 2845 - 2850
  • [4] Response to a preventive HER2/neu peptide (E75) vaccine based on HER2/neu status
    Benavides, Linda C.
    Gates, Jeremy D.
    Carmichael, Mark G.
    Holmes, Jarrod P.
    Hueman, Matthew T.
    Mittendorf, Elizabeth A.
    Patil, Ritesh
    Stojadinovic, Alexander
    Craig, Dianna
    Ponniah, Sathibalan
    Peoples, George E.
    CANCER RESEARCH, 2008, 68 (09)
  • [5] Early results of combined Her-2/neu (HER2) immunotherapy using a HER2 peptide vaccine with concurrent trastuzumab for metastatic breast cancer.
    Webster, D.
    Waisman, J.
    MacLeod, B.
    dela Rosa, C.
    Higgins, D.
    Fintak, P.
    Childs, J.
    Slota, M.
    Salazar, L.
    Disis, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S79 - S80
  • [6] The E75 HER2/neu peptide vaccine
    Elizabeth A. Mittendorf
    Jarrod P. Holmes
    Sathibalan Ponniah
    George E. Peoples
    Cancer Immunology, Immunotherapy, 2008, 57 : 1511 - 1521
  • [7] The E75 HER2/neu peptide vaccine
    Mittendorf, Elizabeth A.
    Holmes, Jarrod P.
    Ponniah, Sathibalan
    Peoples, George E.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2008, 57 (10) : 1511 - 1521
  • [8] Peptide vaccine strategy for immunotherapy of HER-2/neu overexpressing cancers
    Dakappagari, N
    Woodbine, DB
    Triozzi, P
    Stevens, V
    Kaumaya, PTP
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 700 - 701
  • [9] HER-2/neu peptide vaccine for the prevention of prostate cancer recurrence
    Katherine Sole
    Nature Clinical Practice Urology, 2006, 3 (1): : 6 - 6
  • [10] Adjuvant HER2/neu peptide cancer vaccines in breast cancer
    Clifton, Guy T.
    Mittendorf, Elizabeth A.
    Peoples, George E.
    IMMUNOTHERAPY, 2015, 7 (11) : 1159 - 1168
12345